Japan approves dexamethasone as coronavirus treatment
Tokyo: Japan’s health ministry has approved dexamethasone, a cheap and widely used steroid, as a second treatment of COVID-19 after a trial in Britain showed the drug reduced death rates in hospitalised patients.
The ministry included dexamethasone as an option for treatment along with Gilead Sciences Inc’s antiviral drug remdesivir in a recent revision to its handbook.
Avalanche alert in North Kashmir above 2,600m
Srinagar: Jammu and Kashmir Union Territory Disaster Management Authority on Friday issued…


